Medpace Holdings, Inc.
MEDP
Kedudukan dalam Saham
#1291
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Harga Saham
$628.84
Modal Pasaran
$17.55B
Perubahan (1 hari)
1.48%
Perubahan (1 tahun)
15.51%
Negara
US
Perdagangan Medpace Holdings, Inc. (MEDP)
Kategori
Healthcare
Nisbah P/S bagi Medpace Holdings, Inc. (MEDP)
Nisbah P/S pada October 2026 TTM: 6.19
Menurut laporan kewangan dan harga saham terkini Medpace Holdings, Inc., nisbah P/S semasa (TTM) ialah 6.19. Pada akhir 2024, nisbah P/S syarikat ialah 4.88.
Sejarah nisbah P/S untuk Medpace Holdings, Inc. dari 2013 hingga 2026
Nisbah P/S pada akhir setiap tahun
| Tahun | Nisbah P/S | Ubah |
|---|---|---|
| 2026 (TTM) | 6.19 | -3.34% |
| 2025 | 6.40 | 31.31% |
| 2024 | 4.88 | -2.35% |
| 2023 | 4.99 | 5.98% |
| 2022 | 4.71 | -31.03% |
| 2021 | 6.83 | 27.53% |
| 2020 | 5.36 | 52.92% |
| 2019 | 3.50 | 31.19% |
| 2018 | 2.67 | -17.76% |
| 2017 | 3.25 | 6.33% |
| 2016 | 3.05 | -0.45% |
| 2015 | 3.07 | 8.77% |
| 2014 | 2.82 | -27.78% |
| 2013 | 3.91 | 0.00% |
Nisbah P/S untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/S | Perbezaan Nisbah P/S | Negara |
|---|---|---|---|
| 5.37 | -13.16% |
US
|
|
| 6.29 | 1.72% |
US
|
|
| 21.02 | 239.79% |
US
|
|
| - | - |
CN
|
|
| 6.67 | 7.76% |
US
|
